Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The 4 Companies Teaming Up For A New Tool To Fight Cancer
Yahoo/Benzinga
Monday, August 25, 2014 - 10:17pm
tags:
cancer, JNJ, Illumina, AstraZeneca, Sanofi, MiSeqDx, DNA sequencing
FDA grants orphan drug designation to potential Insys brain cancer treatment
Yahoo/AP
Monday, August 25, 2014 - 12:00pm
tags:
Insys, orphan drugs, FDA, CBD, glioblastoma multiforme
There's still hunger for 'blockbuster' biotech deals
CNBC
Monday, August 25, 2014 - 11:58am
tags:
biotech, Roche, InterMune, M&A
Former FDA head says biotech business model 'is basically falling apart'
Bizjournals.com
Monday, August 25, 2014 - 10:25am
tags:
FDA, biotech
J&J Paid Over $150K to Doctor Who Sat on FDA Safety Panels
New Brunswick Today, NJ
Monday, August 25, 2014 - 10:24am
tags:
JNJ, FDA, physician payments
Roche And InterMune Beckon Pharma's Summer of Discontent
Forbes
Monday, August 25, 2014 - 9:59am
tags:
Roche, InterMune, M&A
Galena Fires CEO Ahn, Offers No Parting Gifts
TheStreet.com
Monday, August 25, 2014 - 9:57am
tags:
Galena Biopharma, firings, Pharma CEOs, Mark Ahn
Kindred Biosciences Falls on Disappointing CereKin Data
Yahoo/Zacks.com
Monday, August 25, 2014 - 9:56am
tags:
Kindred Biosciences, CereKin, animal health, osteoarthritis
Vivus acquires patent rights to Qsymia ingredient
Yahoo/AP
Monday, August 25, 2014 - 9:54am
tags:
Vivus, patents, Qsymia, Janssen, JNJ
Roche Said to Have Decided Against Bid for Rest of Chugai
Bloomberg
Monday, August 25, 2014 - 9:10am
tags:
Roche, Chugai, M&A, InterMune
The real 'exclusive' at Merck: R&D is back in the saddle, baby
Fierce Biotech
Monday, August 25, 2014 - 8:48am
tags:
Merck, R&D, melanoma, Pembrolizumab
Roche CEO On Intermune Deal: 'This Is A Growth Story'
Forbes
Monday, August 25, 2014 - 8:37am
tags:
Pharma CEOs, InterMune, Roche, M&A, Severin Schwan
Allergan reviewing special meeting requests as Valeant ratchets up $53B hostile takeover bid
Yahoo/AP
Monday, August 25, 2014 - 8:33am
tags:
M&A, Valeant Pharmaceuticals, Allergan
Valeant Says Allergan Investors Demand Meeting on Deal
Bloomberg
Monday, August 25, 2014 - 8:32am
tags:
Allergan, Valeant Pharmaceuticals, M&A
Regado permanantly halts enrollment in lead drug trial
Yahoo/AP
Monday, August 25, 2014 - 8:27am
tags:
Regado Biosciences, clinical trials, Revolixys, bloodthinners
3 Pharma Companies That Could Deliver Breakthroughs In 'Plantibody' Technology
Yahoo/Benzinga
Monday, August 25, 2014 - 8:25am
tags:
genetic engineering, plantibodies, antibodies, iBio, PlantForm, Protalix BioTherapeutics
Roche to buy U.S. biotech firm InterMune for $8.3 billion
Yahoo/Reuters
Monday, August 25, 2014 - 8:20am
tags:
Roche, InterMune, M&A
Advaxis, Merck to test immune therapies against prostate cancer
Yahoo/Reuters
Monday, August 25, 2014 - 8:19am
tags:
Advaxis, Merck, prostate cancer, immuno-oncology
Roche's InterMune Acquisition Underscores How It And Pfizer Are On Different M&A Paths
Forbes
Monday, August 25, 2014 - 8:14am
tags:
Roche, InterMune, Pfizer, M&A
Mylan Launches First Generic Klor-Con Extended-Release Tablets
Sys-Con Media
Sunday, August 24, 2014 - 8:51am
tags:
Mylan, generics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.